Furthermore, CML also induced an inflammatory environment in the GI tract characterized by increased expression of IL-6, IFN-γ, TNF-α, IL-22, and GM-CSF in the ileum and colon (Fig. 7c). The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.